机译:肝移植后,患有静态剂量氟康唑的靶向真菌预防方案显着降低了侵袭性真菌感染
Department of PharmacyUniversity of Wisconsin Hospital and ClinicsMadison WI USA;
Department of PharmacyUniversity of Wisconsin Hospital and ClinicsMadison WI USA;
Division of Transplantation Department of SurgeryUniversity of Wisconsin‐Madison School of;
Division of Transplantation Department of SurgeryUniversity of Wisconsin‐Madison School of;
Division of Infectious Disease Department of MedicineUniversity of Wisconsin‐Madison School of;
Division of Infectious Disease Department of MedicineUniversity of Wisconsin‐Madison School of;
Division of Transplantation Department of SurgeryUniversity of Wisconsin‐Madison School of;
Division of Transplantation Department of SurgeryUniversity of Wisconsin‐Madison School of;
antifungals; fungal infections; hepatic; prophylaxis; transplantation;
机译:肝移植后,患有静态剂量氟康唑的靶向真菌预防方案显着降低了侵袭性真菌感染
机译:一种多中心,随机的开放标签研究,可比较Micafungin与氟康唑在预防侵袭性肝脏移植受者的侵袭性真菌感染中的预防
机译:阿尼芬净与氟康唑随机,双盲试验用于预防高危肝移植受者侵袭性真菌感染
机译:肾脏移植术后真菌感染的调查
机译:影响移植患者侵袭性真菌感染风险的行为因素。
机译:米卡芬净联合氟康唑和氟康唑单独应用对预防骨髓或外周干细胞移植的成年患者真菌感染的药代动力学和最大耐受剂量研究
机译:巴西南部异体骨髓移植(allo-BMT)后的81感染:尽管低剂量氟康唑预防性接种,侵袭性真菌感染的发生率仍然较低